Clay M A, Pyle D H, Rye K A, Barter P J
The University of Adelaide, Department of Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000, Australia.
J Biol Chem. 2000 Mar 24;275(12):9019-25. doi: 10.1074/jbc.275.12.9019.
Previous studies have provided detailed information on the formation of spherical high density lipoproteins (HDL) containing apolipoprotein (apo) A-I but no apoA-II (A-I HDL) by an lecithin:cholesterol acyltransferase (LCAT)-mediated process. In this study we have investigated the formation of spherical HDL containing both apoA-I and apoA-II (A-I/A-II HDL). Incubations were carried out containing discoidal A-I reconstituted HDL (rHDL), discoidal A-II rHDL, and low density lipoproteins in the absence or presence of LCAT. After the incubation, the rHDL were reisolated and subjected to immunoaffinity chromatography to determine whether A-I/A-II rHDL were formed. In the absence of LCAT, the majority of the rHDL remained as either A-I rHDL or A-II rHDL, with only a small amount of A-I/A-II rHDL present. By contrast, when LCAT was present, a substantial proportion of the reisolated rHDL were A-I/A-II rHDL. The identity of the particles was confirmed using apoA-I rocket electrophoresis. The formation of the A-I/A-II rHDL was influenced by the relative concentrations of the precursor discoidal A-I and A-II rHDL. The A-I/A-II rHDL included several populations of HDL-sized particles; the predominant population having a Stokes' diameter of 9.9 nm. The particles were spherical in shape and had an electrophoretic mobility slightly slower than that of the alpha-migrating HDL in human plasma. The apoA-I:apoA-II molar ratio of the A-I/A-II rHDL was 0.7:1. Their major lipid constituents were phospholipids, unesterified cholesterol, and cholesteryl esters. The results presented are consistent with LCAT promoting fusion of the A-I rHDL and A-II rHDL to form spherical A-I/A-II rHDL. We suggest that this process may be an important source of A-I/A-II HDL in human plasma.
先前的研究已经提供了关于通过卵磷脂胆固醇酰基转移酶(LCAT)介导的过程形成含有载脂蛋白(apo)A-I但不含apoA-II的球形高密度脂蛋白(HDL)(A-I HDL)的详细信息。在本研究中,我们研究了同时含有apoA-I和apoA-II的球形HDL(A-I/A-II HDL)的形成。在不存在或存在LCAT的情况下,进行含有盘状A-I重组HDL(rHDL)、盘状A-II rHDL和低密度脂蛋白的孵育。孵育后,重新分离rHDL并进行免疫亲和层析以确定是否形成了A-I/A-II rHDL。在不存在LCAT的情况下,大多数rHDL保持为A-I rHDL或A-II rHDL,仅存在少量A-I/A-II rHDL。相比之下,当存在LCAT时,重新分离的rHDL中有很大一部分是A-I/A-II rHDL。使用apoA-I火箭电泳确认了颗粒的身份。A-I/A-II rHDL的形成受前体盘状A-I和A-II rHDL相对浓度的影响。A-I/A-II rHDL包括几个HDL大小颗粒的群体;主要群体的斯托克斯直径为9.9 nm。颗粒呈球形,电泳迁移率略慢于人类血浆中α迁移HDL的迁移率。A-I/A-II rHDL的apoA-I:apoA-II摩尔比为0.7:1。它们的主要脂质成分是磷脂、未酯化胆固醇和胆固醇酯。所呈现的结果与LCAT促进A-I rHDL和A-II rHDL融合以形成球形A-I/A-II rHDL一致。我们认为该过程可能是人类血浆中A-I/A-II HDL的重要来源。